Conjugative Botulinum Neurotoxin-encoding Plasmids in Clostridium Botulinum

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2010 Jun 17

PMID 20552020

Citations 29

Authors

Kristin M Marshall

Marite Bradshaw

Eric A Johnson

Affiliations

Soon will be listed here.

Abstract

Background: Clostridium botulinum produces seven distinct serotypes of botulinum neurotoxins (BoNTs). The genes encoding different subtype neurotoxins of serotypes A, B, F and several dual neurotoxin-producing strains have been shown to reside on plasmids, suggesting that intra- and interspecies transfer of BoNT-encoding plasmids may occur. The objective of the present study was to determine whether these C. botulinum BoNT-encoding plasmids are conjugative.

Methodology/principal Findings: C. botulinum BoNT-encoding plasmids pBotCDC-A3 (strain CDC-A3), pCLJ (strain 657Ba) and pCLL (strain Eklund 17B) were tagged with the erythromycin resistance marker (Erm) using the ClosTron mutagenesis system by inserting a group II intron into the neurotoxin genes carried on these plasmids. Transfer of the tagged plasmids from the donor strains CDC-A3, 657Ba and Eklund 17B to tetracycline-resistant recipient C. botulinum strains was evaluated in mating experiments. Erythromycin and tetracycline resistant transconjugants were isolated from donor:recipient mating pairs tested. Transfer of the plasmids to the transconjugants was confirmed by pulsed-field gel electrophoresis (PFGE) and Southern hybridizations. Transfer required cell-to-cell contact and was DNase resistant. This indicates that transfer of these plasmids occurs via a conjugation mechanism.

Conclusions/significance: This is the first evidence supporting conjugal transfer of native botulinum neurotoxin-encoding plasmids in C. botulinum, and provides a probable mechanism for the lateral distribution of BoNT-encoding plasmids to other C. botulinum strains. The potential transfer of C. botulinum BoNT-encoding plasmids to other bacterial hosts in the environment or within the human intestine is of great concern for human pathogenicity and necessitates further characterization of these plasmids.

Citing Articles

Expression of Recombinant Clostridial Neurotoxin by .

Gregg B, Gupta S, Tepp W, Pellett S Microorganisms. 2025; 12(12.

PMID: 39770813 PMC: 11678509. DOI: 10.3390/microorganisms12122611.

Pathogenicity and virulence of .

Rawson A, Dempster A, Humphreys C, Minton N Virulence. 2023; 14(1):2205251.

PMID: 37157163 PMC: 10171130. DOI: 10.1080/21505594.2023.2205251.

Endogenous CRISPR-Cas Systems in Group I and Do Not Directly Target the Botulinum Neurotoxin Gene Cluster.

Wentz T, Tremblay B, Bradshaw M, Doxey A, Sharma S, Sauer J Front Microbiol. 2022; 12:787726.

PMID: 35222299 PMC: 8865420. DOI: 10.3389/fmicb.2021.787726.

The Distinctive Evolution of Strains and Their Botulinum Neurotoxin Type A and F Gene Clusters Is Influenced by Environmental Factors and Gene Interactions via Mobile Genetic Elements.

Smith T, Williamson C, Hill K, Johnson S, Xie G, Anniballi F Front Microbiol. 2021; 12:566908.

PMID: 33716993 PMC: 7952441. DOI: 10.3389/fmicb.2021.566908.

Genomic Characterization of Newly Completed Genomes of Botulinum Neurotoxin-Producing Species from Argentina, Australia, and Africa.

Smith T, Xie G, Williamson C, Hill K, Fernandez R, Sahl J Genome Biol Evol. 2020; 12(3):229-242.

PMID: 32108238 PMC: 7144720. DOI: 10.1093/gbe/evaa043.

References

Zhou Y, Sugiyama H, Nakano H, Johnson E . The genes for the Clostridium botulinum type G toxin complex are on a plasmid. Infect Immun. 1995; 63(5):2087-91. PMC: 173270. DOI: 10.1128/iai.63.5.2087-2091.1995. View

Bannam T, Teng W, Bulach D, Lyras D, Rood J . Functional identification of conjugation and replication regions of the tetracycline resistance plasmid pCW3 from Clostridium perfringens. J Bacteriol. 2006; 188(13):4942-51. PMC: 1483020. DOI: 10.1128/JB.00298-06. View

Dover N, Barash J, Arnon S . Novel Clostridium botulinum toxin gene arrangement with subtype A5 and partial subtype B3 botulinum neurotoxin genes. J Clin Microbiol. 2009; 47(7):2349-50. PMC: 2708499. DOI: 10.1128/JCM.00799-09. View

Hill K, Smith T, Helma C, Ticknor L, Foley B, Svensson R . Genetic diversity among Botulinum Neurotoxin-producing clostridial strains. J Bacteriol. 2006; 189(3):818-32. PMC: 1797315. DOI: 10.1128/JB.01180-06. View

Wang X, MAEGAWA T, Karasawa T, Kozaki S, Tsukamoto K, Gyobu Y . Genetic analysis of type E botulinum toxin-producing Clostridium butyricum strains. Appl Environ Microbiol. 2000; 66(11):4992-7. PMC: 92410. DOI: 10.1128/AEM.66.11.4992-4997.2000. View

Darling A, Mau B, Blattner F, Perna N . Mauve: multiple alignment of conserved genomic sequence with rearrangements. Genome Res. 2004; 14(7):1394-403. PMC: 442156. DOI: 10.1101/gr.2289704. View

Arndt J, Jacobson M, Abola E, Forsyth C, Tepp W, Marks J . A structural perspective of the sequence variability within botulinum neurotoxin subtypes A1-A4. J Mol Biol. 2006; 362(4):733-42. DOI: 10.1016/j.jmb.2006.07.040. View

Jacobson M, Lin G, Whittam T, Johnson E . Phylogenetic analysis of Clostridium botulinum type A by multi-locus sequence typing. Microbiology (Reading). 2008; 154(Pt 8):2408-2415. PMC: 2562668. DOI: 10.1099/mic.0.2008/016915-0. View

Hill K, Xie G, Foley B, Smith T, Munk A, Bruce D . Recombination and insertion events involving the botulinum neurotoxin complex genes in Clostridium botulinum types A, B, E and F and Clostridium butyricum type E strains. BMC Biol. 2009; 7:66. PMC: 2764570. DOI: 10.1186/1741-7007-7-66. View

10.

Rood J, Scott V, Duncan C . Identification of a transferable tetracycline resistance plasmid (pCW3) from Clostridium perfringens. Plasmid. 1978; 1(4):563-70. DOI: 10.1016/0147-619x(78)90013-6. View

11.

Lin W, Johnson E . Transposon Tn916 mutagenesis in Clostridium botulinum. Appl Environ Microbiol. 1991; 57(10):2946-50. PMC: 183902. DOI: 10.1128/aem.57.10.2946-2950.1991. View

12.

Heap J, Kuehne S, Ehsaan M, Cartman S, Cooksley C, Scott J . The ClosTron: Mutagenesis in Clostridium refined and streamlined. J Microbiol Methods. 2009; 80(1):49-55. DOI: 10.1016/j.mimet.2009.10.018. View

13.

Smith T, Hill K, Foley B, Detter J, Munk A, Bruce D . Analysis of the neurotoxin complex genes in Clostridium botulinum A1-A4 and B1 strains: BoNT/A3, /Ba4 and /B1 clusters are located within plasmids. PLoS One. 2007; 2(12):e1271. PMC: 2092393. DOI: 10.1371/journal.pone.0001271. View

14.

Schiavo G, Matteoli M, Montecucco C . Neurotoxins affecting neuroexocytosis. Physiol Rev. 2000; 80(2):717-66. DOI: 10.1152/physrev.2000.80.2.717. View

15.

Sakaguchi Y, Hayashi T, Kurokawa K, Nakayama K, Oshima K, Fujinaga Y . The genome sequence of Clostridium botulinum type C neurotoxin-converting phage and the molecular mechanisms of unstable lysogeny. Proc Natl Acad Sci U S A. 2005; 102(48):17472-7. PMC: 1283531. DOI: 10.1073/pnas.0505503102. View

16.

Bradshaw M, Dineen S, Maks N, Johnson E . Regulation of neurotoxin complex expression in Clostridium botulinum strains 62A, Hall A-hyper, and NCTC 2916. Anaerobe. 2006; 10(6):321-33. DOI: 10.1016/j.anaerobe.2004.07.001. View

17.

Peck M . Biology and genomic analysis of Clostridium botulinum. Adv Microb Physiol. 2009; 55:183-265, 320. DOI: 10.1016/S0065-2911(09)05503-9. View

18.

Carter A, Paul C, Mason D, Twine S, Alston M, Logan S . Independent evolution of neurotoxin and flagellar genetic loci in proteolytic Clostridium botulinum. BMC Genomics. 2009; 10:115. PMC: 2674064. DOI: 10.1186/1471-2164-10-115. View

19.

Neve H, Geis A, Teuber M . Conjugal transfer and characterization of bacteriocin plasmids in group N (lactic acid) streptococci. J Bacteriol. 1984; 157(3):833-8. PMC: 215335. DOI: 10.1128/jb.157.3.833-838.1984. View

20.

Franciosa G, Maugliani A, Scalfaro C, Aureli P . Evidence that plasmid-borne botulinum neurotoxin type B genes are widespread among Clostridium botulinum serotype B strains. PLoS One. 2009; 4(3):e4829. PMC: 2653641. DOI: 10.1371/journal.pone.0004829. View